🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Screening

The Ohio State University (OSU) SCREEN Community Program NCT06666192NA1 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Cancer Screening, Discussion, Educational Activity, Educational Intervention, Focus Group Retinal Fundus Imaging and OCT Imaging for Ocular Detection of ATTR-CM NCT07690436n/a20 sites📍 Palo Alto📍 Jacksonville📍 Chicago AstraZeneca Prediction Augmented Screening Initiative NCT06538636NA4 sites📍 Bedford📍 Boston📍 Ann Arbor VA Office of Research and Development · Tests: PCP-Facing Tools, LCS team population management tools Involvement of General Practitioners in Lung Cancer Screening NCT06956040NA1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Low-dose computed tomography of the chest Screening for Anal Cancer in Men Who Have Sex With Men Using Pre-Exposure Prophylaxis NCT07029152NA8 sites📍 Bruges📍 Brussels📍 Brussels Universitair Ziekenhuis Brussel · Tests: Anal smear, Self-administered questionnaire, EQ-5D-5L questionnaire, High Resolution Anoscopy (HRA) Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers NCT05553782EARLY Phase 12 sites📍 Boston📍 Boston Brigham and Women's Hospital · Tests: Implantable Microdevice (IMD) Aspergillus Infection in Patients Admitted to Hematology Ward NCT07440485n/a1 site📍 Pavia Fondazione IRCCS Policlinico San Matteo di Pavia Global Research Initiative for Patients Screening on MASH NCT05651724n/a13 sites📍 Brussels📍 Antwerp📍 Prague Julius Clinical Smartwatch-Based AI Model for OSA Prediction (SWOSA) NCT06792188n/a1 site📍 Seoul Seoul National University Hospital · Tests: Galaxy Watch 4, Samsung Electronics Co., Ltd., South Korea Implementation of Anal Cancer Screening and Treatment in Nigeria NCT05817370NA1 site📍 Abuja University of Maryland, Baltimore · Tests: Enhanced Training on screening and treatment of HSIL (e-STH) Epstein-Barr Virus Antibody and Epstein-Barr Virus DNA for Nasopharyngeal Carcinoma Screening NCT05447169n/a1 site📍 Guangzhou Sun Yat-sen University · Tests: EBV antibodies test, EBV DNA test Precision Navigation to Improve Community Cancer Screening Participation NCT07676383NA3 sites📍 Huaihua📍 Shaoyang📍 Yongzhou Hunan Cancer Hospital · Tests: Precision Navigation Intervention, Usual Health Education Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic NCT06329531n/a1 site📍 Houston M.D. Anderson Cancer Center · Tests: Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Akershus Cardiac Examination (ACE) 5 Study NCT07301489NA1 site📍 Lørenskog University Hospital, Akershus · Tests: Lung Cancer Screening Plus Program, Standard of Care Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study NCT07557303NA3 sites📍 San Francisco📍 Jacksonville📍 Chapel Hill Case Western Reserve University · Tests: Mobile-based Educational Intervention Methylated Biomarkers of Smoking as a Selection Tool in Participants for Lung Cancer Screening NCT07631624NA1 site📍 Antwerp University Hospital, Antwerp · Tests: DNA-methylation in saliva Effect of Daily Screen Time on Postoperative Emergence Delirium in Children Aged 2-11 Years NCT07552896n/a1 site📍 Istanbul Kanuni Sultan Suleyman Training and Research Hospital · Tests: Daily Screen Exposure Duration Cognitive Screening in Lung Cancer Patients NCT06727370n/a1 site📍 Milan European Institute of Oncology Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations NCT07143669n/a26 sites📍 Birmingham📍 Birmingham📍 Scottsdale Blueprint Medicines Corporation · Tests: Screening Vision-Language-Based Large-Scale Model for Emergency Screening NCT07899931NA1 site📍 Changchun The First Hospital of Jilin University · Tests: powER vision-language large-model assisted CT reading, Conventional CT reading without AI assistance The Cancer Stage Shifting Initiative: Registry and Biorepository to Research and Address Health Disparities in Cancer Care NCT07461493n/a2 sites📍 Flint📍 Houston National Minority Quality Forum Community, Home-based Education, Screening Services Strategy to Increase Cervical Cancer Control Access for HIV-Positive Women in Nigeria NCT06751030n/a3 sites📍 Abuja📍 Ibadan📍 Lagos Emory University · Tests: The Mother Mentor program, GeneXpert HPV test Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates NCT04606693NA1 site📍 Madrid Hospital San Carlos, Madrid · Tests: Treatment of SAHS Bridging the Gap in Psychosocial Care for Cancer Survivors NCT07672314NA1 site📍 Basel University Hospital, Basel, Switzerland · Tests: Navigation Call Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer NCT06743308NA1 site📍 Houston M.D. Anderson Cancer Center · Tests: Best Practice, Questionnaire Administration Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study NCT06619106n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Cognitive test Singula Phase 0.1 Primary Care Pilot NCT07834684n/a2 sites📍 Brentwood📍 Mount Kisco Singula Health, Inc. Prevention of Preeclampsia in Denmark: A National Implementation Study NCT07485140n/a3 sites📍 Aarhus📍 Copenhagen📍 Hillerød Copenhagen University Hospital at Herlev · Tests: First trimester screening for preeclampsia Genetic Assessment of Breast Cancer Risk in Women in the DORA Programme NCT07734389NA1 site📍 Ljubljana Institute of Oncology Ljubljana · Tests: Comprehensive Clinical and Genetic Breast Cancer Risk Assessment Screening for Research Participants NCT00655096n/a1 site📍 Bethesda National Eye Institute (NEI)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy